Embark Veterinary, Inc.

Embark Veterinary, Inc.

Embark Veterinary, Inc.

Overview
Date Founded

2015

Headquarters

186 Lincoln Street,floor 6,Boston, MA 02111

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Medical Support Services
Consumer Services
Biotechnology
Agriculture & Mills
Hospitals & Patient Services
Holding Companies

Company Description

Embark Veterinary, Inc. provides dog DNA testing services to improve dog health and wellness. The firm offers DNA testing kit for dogs that will include information about a canine''s ancestry and disease risk. The company was founded by Adam Boyko, Spencer Wells, Mark Selzberg, Matthew B. Selzberg and Ryan Boyko in 2015 and is headquartered in Boston, MA.

Contact Data
Trying to get in touch with decision makers at Embark Veterinary, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Founder & Chief Executive Officer

Chief Scientific Officer

Co-Founder & Chief Product Officer

Board of Directors

Co-Founder at Embark Veterinary, Inc.

Paths to Embark Veterinary, Inc.
Potential Connections via
Relationship Science
You
Embark Veterinary, Inc.
Recent Transactions
Details Hidden

Embark Veterinary, Inc. raised money in a private placement transaction

Details Hidden

Embark Veterinary, Inc. raised money in a private placement transaction

Details Hidden

Embark Veterinary, Inc. raised money in a private placement transaction

Investors
Details Hidden

FJ Labs Inc invests in companies located in the US. The firm focuses on technology companies with an investment size from $0.05 to $5 million. They provide financing for seed and early stage capital requirements.FJ Labs Inc invests in companies located in New York City & Bay Area, US. The firm focuses on sectors such as fintech, e-commerce, travel , mobile, Saas, B2B & B2C. It provides financing for seed & early stage capital requirement with an investment size from $0.05 to $5 million & a quality management team.

Details Hidden

Impresa focuses on early-stage investments in start-up companies across US and International portfolio companies. There fund focuses on companies operating in the fields of biopharmaceutical, medical technology & healthcare IT and services.There funds are larger and more global. In the US and Europe, they are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, there sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai with over $2 trillion in assets under management.

Details Hidden

Section 32 invests in companies located in the US. The firm focuses on companies operating in the fields of frontiers of technology,healthcare and the life sciences software, cybersecurity, machine learning, and artificial intelligence. The firm provides financing for early stage capital requirements.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Embark Veterinary, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Embark Veterinary, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Embark Veterinary, Inc..